An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity by Schmidt, Nora et al.
                                                              
University of Dundee
An influenza virus-triggered SUMO switch orchestrates co-opted endogenous
retroviruses to stimulate host antiviral immunity
Schmidt, Nora; Domingues, Patricia; Golebiowski, Filip; Patzina, Corinna; Tatham, Michael H;
Hay, Ronald T; Hale, Benjamin G
Published in:
Proceedings of the National Academy of Sciences of the United States of America
DOI:
10.1073/pnas.1907031116
Publication date:
2019
Document Version
Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Schmidt, N., Domingues, P., Golebiowski, F., Patzina, C., Tatham, M. H., Hay, R. T., & Hale, B. G. (2019). An
influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral
immunity. Proceedings of the National Academy of Sciences of the United States of America, 1-10.
https://doi.org/10.1073/pnas.1907031116
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
An influenza virus-triggered SUMO switch orchestrates
co-opted endogenous retroviruses to stimulate host
antiviral immunity
Nora Schmidta, Patricia Dominguesa,1,2, Filip Golebiowskia,1, Corinna Patzinaa,3, Michael H. Tathamb, Ronald T. Hayb,
and Benjamin G. Halea,4
aInstitute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland; and bCentre for Gene Regulation and Expression, School of Life Sciences,
University of Dundee, DD1 5EH Dundee, United Kingdom
Edited by Stephen P. Goff, Columbia University Medical Center, New York, NY, and approved July 15, 2019 (received for review April 24, 2019)
Dynamic small ubiquitin-like modifier (SUMO) linkages to diverse
cellular protein groups are critical to orchestrate resolution of stresses
such as genome damage, hypoxia, or proteotoxicity. Defense against
pathogen insult (often reliant upon host recognition of “non-self”
nucleic acids) is also modulated by SUMO, but the underlying mech-
anisms are incompletely understood. Here, we used quantitative
SILAC-based proteomics to survey pan-viral host SUMOylation re-
sponses, creating a resource of almost 600 common and unique
SUMO remodeling events that are mounted during influenza A and
B virus infections, as well as during viral innate immune stimulation.
Subsequent mechanistic profiling focused on a common infection-
induced loss of the SUMO-modified form of TRIM28/KAP1, a host
transcriptional repressor. By integrating knockout and reconstitution
models with system-wide transcriptomics, we provide evidence that
influenza virus-triggered loss of SUMO-modified TRIM28 leads to de-
repression of endogenous retroviral (ERV) elements, unmasking this
cellular source of “self” double-stranded (ds)RNA. Consequently, loss
of SUMO-modified TRIM28 potentiates canonical cytosolic dsRNA-
activated IFN-mediated defenses that rely on RIG-I, MAVS, TBK1,
and JAK1. Intriguingly, although wild-type influenza A virus robustly
triggers this SUMO switch in TRIM28, the induction of IFN-stimulated
genes is limited unless expression of the viral dsRNA-binding protein
NS1 is abrogated. This may imply a viral strategy to antagonize such a
host response by sequestration of induced immunostimulatory ERV
dsRNAs. Overall, our data reveal that a key nuclear mechanism that
normally prevents aberrant expression of ERV elements (ERVs) has
been functionally co-opted via a stress-induced SUMO switch to
augment antiviral immunity.
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Acritical component of how individual cells and tissues de-fend themselves against invading viruses is the ability to
detect the abnormality of infection and mount an appropriate
antiviral response. The host innate IFN system is a powerful first
line of defense against pathogens, and typically involves specific
cellular recognition of non-self pathogen-associated molecular
patterns (PAMPs), such as viral nucleic acids or capsids, by host
pattern recognition receptors (PRRs), which then become acti-
vated to trigger expression and secretion of IFN cytokines (1).
IFNs function in a paracrine or autocrine fashion to induce
hundreds of IFN-stimulated gene (ISG) products that harbor
diverse antiviral mechanisms and act to limit virus replication
and spread (2). Key to the integrity of this cellular system is the
tight discrimination of “self” from “non-self” (3), which also in-
volves repressing, shielding, or modifying endogenous self nucleic
acids with immunostimulatory potential to prevent development of
aberrant immunopathologies (4–10). Nevertheless, new research is
beginning to uncover previously unappreciated roles for self nucleic
acid species that accumulate during the abnormal conditions of a
viral infection, and which trigger activation of antiviral immunity via
canonical PRRs (11–13). Such studies are driving the intriguing
hypothesis that stress-induced host-derived self elements may have
been co-opted to promote antiviral IFN-mediated defenses.
SUMOylation is a dynamic posttranslational modification of
protein lysine residues that is crucial for regulating many cellular
processes, including transcription, mRNA processing, chromatin
remodeling, DNA replication, and DNA damage responses (14).
Importantly, SUMOylation is highly stress-responsive, and is a
critical mediator in the resolution of cellular insults, including
hypoxia, heat shock, and genotoxic stresses (15). The small
ubiquitin-like modifier (SUMO) system also plays key roles in
the host response to viral infections (16), specifically by fine-
tuning the functions of PRRs involved in the sensing of viral
nucleic acids (17, 18), and by coordinating the repression of
exuberant IFN stimulation (19, 20).
Significance
Primary host defenses against viruses involve specific cellular
recognition of non-self nucleic acids as pathogen-associated
molecular patterns (PAMPs) that trigger induction of cytokine-
mediated antiviral responses. Thus, ability to discriminate be-
tween “self” and “non-self” nucleic acids, and prevent aberrant
immunopathology, is a key tenet of immunity. Here, we iden-
tify self-derived endogenous retroviral RNAs as host-encoded
PAMPs that are up-regulated during influenza virus infections,
and which stimulate antiviral immunity. Normally, endogenous
retroviruses are tightly repressed transcriptionally by host
TRIM28, but infection triggers changes in the modification
status of TRIM28 to alleviate repression. This provides an ex-
ample of how endogenous retroviruses integrated within the
host genome have been functionally co-opted by a regulatory
switch to aid defense against newly invading pathogens.
Author contributions: N.S., P.D., F.G., and B.G.H. designed research; N.S., P.D., and F.G.
performed research; C.P., M.H.T., and R.T.H. contributed new reagents/analytic tools; N.S.,
P.D., F.G., M.H.T., R.T.H., and B.G.H. analyzed data; and N.S. and B.G.H. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This open access article is distributed under Creative Commons Attribution License 4.0
(CC BY).
Data deposition: The raw mass spectrometry proteomics data reported in this paper have
been deposited in the ProteomeXchange Consortium via the PRIDE partner repository
(identifier no. PXD014136). The RNA-seq data reported in this paper have been deposited
in NCBI’s Gene Expression Omnibus (GEO) database, https://www.ncbi.nlm.nih.gov/geo
(accession no. GSE133329).
1P.D. and F.G. contributed equally to this work.
2Present address: Department of Pathology, Addenbrooke’s Hospital, University of Cam-
bridge, CB2 0QQ Cambridge, United Kingdom.
3Present address: German Federal Institute for Risk Assessment, 10589 Berlin, Germany.
4To whom correspondence may be addressed. Email: hale.ben@virology.uzh.ch.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1907031116/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1907031116 PNAS Latest Articles | 1 of 10
IM
M
U
N
O
LO
G
Y
A
N
D
IN
FL
A
M
M
A
TI
O
N
In this study, we sought to explore the interplay between stress-
responsive SUMOylation and host antiviral defenses by conducting
a proteome-wide survey of SUMO modification dynamics during
infection with influenza virus variants that differ in their abilities to
stimulate host IFN responses. Analysis of highly infection-regulated
SUMO targets led us to focus follow-up studies on the host factor
tripartite motif-containing-28 (TRIM28, also known as KAP1 or
TIF1β), which has recently been implicated in contributing to in-
flammatory cytokine production during viral infection (21). Notably,
TRIM28 is a transcriptional corepressor that acts in concert with
KRAB-ZNFs (Krüppel-associated box domain-zinc finger pro-
teins), SUMO, the histone methyltransferase SETDB1, and the
nucleosome remodeling and deacetylation (NuRD) complex to
induce heterochromatin formation and repress endogenous retro-
viral (ERV) element transcription (22–27). Such silencing of ERV
elements (ERVs) is critical to limit aberrant IFN responses, as
artificial derepression of ERV transcripts leads to formation of
double-stranded RNA (dsRNA) that is sensed as non-self by PRRs
(5–10). Here, we provide evidence that this regulatory mechanism
has also been physiologically co-opted by host cells as part of a
strategy to promote innate immunity: A noncanonical infection-
triggered SUMO switch in TRIM28 promotes ERV expression
and enhances subsequent stimulation of IFN-mediated antiviral
defenses. Our data add insights into how mammals have evolved to
take advantage of non-self elements integrated within their ge-
nomes, and provide an example of how traditional self versus non-
self rules have been usurped in order to counteract virus infection.
Results
Quantitative Proteomics Identifies Conserved and Unique Features of
Host SUMOylation Responses to Different Influenza Virus Infections.
We extended our previous survey of the host SUMOylation re-
sponse to influenza A virus (IAV) infection (28) by applying quan-
titative proteomic strategies to identify cellular proteins that change
in SUMO modification status following infection with the distantly
related influenza B virus (IBV), or an IAV strain engineered to lack
expression of its major IFN-antagonist protein, NS1 (IAVΔNS1).
Our previous analysis of IAV infection-induced quantitative changes
to SUMO1 and SUMO2 conjugation demonstrated a very high
degree of correlation between the 2 paralogs (28), indicating that
data obtained from either system can represent a common and
stringent consensus of SUMO substrate changes. Thus, for each
virus, we conducted 2 independent “label-swap” stable isotope la-
beling by amino acids in cell culture (SILAC) experiments using an
A549 cell line stably expressing N-terminal tandem-affinity purifi-
cation (TAP)-tagged SUMO2 to determine the impact of infection
on the SUMO subproteome (Fig. 1A). Analysis of average infection-
induced changes to total proteome abundance revealed that, in
contrast to IAV, both IBV and IAVΔNS1 infections triggered a
classical host IFN response consisting of several ISG products, in-
cluding ISG15, ISG20, MDA5, MxA, IFIT1, and IFIT3 (Fig. 1 B–D
and Datasets S1–S3). This specific and rapid innate immune acti-
vation by IBV and IAVΔNS1, but not IAV, is consistent with pre-
vious reports (29), and provided us with a unique combination of
experimental outcomes with which to dissect infection-induced
SUMO responses. Strikingly, infection with all viruses induced wide-
spread changes to the host SUMO proteome, which included
both virus-specific increases to certain SUMOmodification events as
well as a common and broad loss of many SUMOylated proteins
(IAV: 83 increased, 270 decreased; IBV: 81 increased, 295 de-
creased; IAVΔNS1: 12 increased, 193 decreased) (Fig. 1 E–G and
Datasets S1–S3). Indeed, infection-induced changes to target pro-
tein SUMOylation correlated well between IAV and IBV infections,
and to a limited extent between IAV and IAVΔNS1 infections,
particularly with regard to the common loss of many SUMOylated
proteins (Fig. 1H and I). It is possible that constrained up-regulation
of SUMOylated proteins by IAVΔNS1 (as compared to IAV) is
because NS1 plays a hitherto unrecognized role in directly stimu-
lating SUMO conjugate appearance, or because IAVΔNS1 is gen-
erally less efficient at replicating than wild-type virus. Pathway
enrichment analyses of each infection-regulated SUMO proteome
with DAVID (30), using all identified SUMO-modified proteins as
background, revealed a remarkably similar enrichment pattern in-
volving mainly transcriptional regulation pathways and chromatin
modification (Fig. 1J and Datasets S1–S3). These data represent a
unique and robust proteomic snapshot of host SUMO remodeling
following diverse infection conditions, and will be an invaluable
resource for dissecting the contribution of specific SUMOylation
events to different aspects of influenza virus biology.
Infection-Induced Loss of SUMOylated TRIM28 Is Independent of
Antiviral RNA-Sensing Pathways, IFN, and Canonical DNA Damage
Responses. We focused our attention on the 71 host substrates
that altered at least 2-fold in SUMO modification status during
all 3 infection conditions (Fig. 2A). SUMOylation changes to
42 of these factors have previously been reported as responsive
to nonviral cellular stresses, such as DNA damage and heat
shock (31), and several are putative proviral IAV host factors
based on meta-analysis of genome-wide RNAi screens (32) (Fig.
2B and Dataset S4). Among these was the transcriptional co-
repressor TRIM28. We confirmed that infection with IAV, IBV,
and IAVΔNS1 leads to loss of posttranslationally modified
TRIM28 (Fig. 2C–E), and validated that this includes SUMOylated
TRIM28 (Fig. 2F). Although TRIM28 can be phosphorylated
in response to viral RNA in a PKR-dependent manner (21),
infection-induced loss of posttranslationally modified TRIM28 was
independent of all canonical antiviral RNA-sensing mechanisms, as
IAV triggered this response even in the absence of RIG-I, MDA5,
PKR, or MAVS (SI Appendix, Fig. S1 A and B), and IFN-α
treatment alone failed to trigger this phenotype (Fig. 2E). Pre-
vious work has suggested that SUMOylated TRIM28 can be
targeted for proteasome-mediated degradation following DNA
damage-induced phosphorylation at Ser824 by the ATM kinase
(33, 34). Unlike the DNA damage-inducing agent etoposide,
IAV failed to trigger TRIM28 phosphorylation at Ser824, and
functional inhibition of either ATM kinase (using KU55933) or
the proteasome (using MG132 or lactacystin) was unable to
prevent loss of posttranslationally modified TRIM28 during in-
fection (SI Appendix, Fig. S1 C–G). These data suggest a pre-
viously undescribed noncanonical mechanism by which influenza
virus induces loss of SUMOylated TRIM28 during infection.
SUMOylated TRIM28 Is Required to Support Efficient Virus Replication.
To analyze the role of TRIM28 during influenza virus replication,
we established A549-based TRIM28 knockout (KO) cell lines using
CRISPR/Cas9 (Fig. 3A and SI Appendix, Fig. S2A). There was no
apparent cell-growth defect in TRIM28-KO cells as compared with
control (Ctrl) cells (Fig. 3B). However, multicycle viral growth
analysis revealed inefficient replication of IAV in 2 independent
TRIM28-KO clones as compared with Ctrl, particularly at late times
postinfection (Fig. 3 C and D and SI Appendix, Fig. S2 B and C).
This phenotype could be reversed by reconstituting the TRIM28-
KO clones with wild-type (wt) TRIM28 via lentiviral transduction
(Fig. 3 A, C, and D and SI Appendix, Fig. S2), indicating a specific
effect. We used this knockout and reconstitution system to un-
derstand the impact that infection-triggered loss of SUMOylated
TRIM28 might have on IAV replication. Six lysine residues in
TRIM28 have previously been reported to be major targets for
SUMO modification (26, 27). We created a TRIM28 mutant con-
struct in which all these 6 lysines were substituted to arginine (6KR;
Fig. 3E) and validated that this TRIM28-6KR construct could no
longer be modified by SUMO1/2 (Fig. 3F). All 6 lysines had to be
simultaneously substituted to arginine to fully ablate TRIM28
SUMOylation, as TRIM28 constructs retaining various combi-
nations of lysines maintained specific SUMOylation profiles (SI Ap-
pendix, Fig. S3 A and B). Strikingly, reconstitution of TRIM28-KO
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cells with the TRIM28-6KR construct failed to result in efficient
IAV replication as compared with reconstitution with wt TRIM28
(Fig. 3 G and H). Reconstitution of TRIM28-KO cells with other
TRIM28 mutant constructs that either retained some SUMOylation
or were lacking the N-terminal RING or C-terminal bromo domains
resulted in partial rescue phenotypes (SI Appendix, Fig. S3), implying
minor contributory roles for these domains. Notably, reconstitution
of TRIM28-KO cells with phosphomimetic or phospho-ablation
mutants of TRIM28 at serine 473 or 824 conferred IAV replica-
tion efficiencies indistinguishable from wt TRIM28 (SI Appendix,
Fig. S4), and IAV-triggered loss of SUMOylated TRIM28 was not
affected by S824A or S824D substitutions (SI Appendix, Fig. S4D),
consistent with our inhibitor studies. These data indicate that com-
plete TRIM28 SUMOylation, but not phosphorylation, supports
efficient viral growth, and suggested to us that noncanonical
infection-triggered loss of SUMOylated TRIM28 may be a cellular
response to limit virus replication.
Cells Expressing SUMOylation-Deficient TRIM28 Exhibit Up-Regulation
of ZNF Family Genes and an Enhanced Innate Immune Defense Gene
Signature. TRIM28 SUMOylation has previously been implicated
in regulating its transcriptional corepressor activity (26, 27). We
therefore performed transcriptomic analyses on TRIM28-KO
cells reconstituted with either wt TRIM28 or TRIM28-6KR to
identify genes differentially expressed between the 2 conditions that
could be candidates regulated by TRIM28 SUMOylation. A large
number of ZNF-related genes (associated with transcriptional
regulation), as well as 3 different ERV envelope genes (ERVV-1,
ERVV-2, and ERV3-1), were more highly expressed in the
TRIM28-6KR cells as compared with wt TRIM28 cells (Fig. 4 A
and B and Dataset S5). This is consistent with recent findings
identifying such genes as repression targets for TRIM28 (9). In
addition, we also detected higher expression of a small number of
innate immunity-related genes, exemplified by ISGs, in the
TRIM28-6KR cells as compared with wt TRIM28 cells. These in-
cluded GBP1, TRIM22, RSAD2 (viperin), and DDX58 (RIG-I)
(Fig. 4 A and B and Dataset S5). These transcriptomic results
were independently confirmed using RT-qPCR assays specific for
several differentially expressed genes (Fig. 4C).
Cells Expressing SUMOylation-Deficient TRIM28 Are Primed for
Triggering Enhanced IFN-Stimulated Responses during Infection.
Given the surprising result that cells expressing SUMOylation-
deficient TRIM28 exhibited an enhanced innate immune gene
Fig. 1. Quantitative proteomics identifies con-
served and unique features of host SUMOylation
responses to different influenza virus infections. (A)
SILAC-based SUMO proteomics workflow. A549 cells
expressing TAP-SUMO1, TAP-SUMO2, or TAP-tag
only were grown in medium containing heavy, me-
dium, or light isotope-labeled amino acids prior to
infection, or mock, with IAV (MOI = 2 PFU per cell,
10 h) (28), IBV (MOI = 5 PFU per cell, 24 h), or
IAVΔNS1 (MOI = 2 PFU per cell, 16 h). Samples of
purified SUMO-modified proteins and total proteins
were subjected to mass spectrometry and quantita-
tive analysis. (B–G) Fold change in total protein
abundance (B–D: purple, viral proteins; orange, ISGs
with fold change ≥4) or SUMO modification (E–G:
red, fold change ≥2; blue, fold change ≤−2) during
infection with IAV (B and E), IBV (C and F), or
IAVΔNS1 (D and G). Note: The datasets for IAV are
reproduced from previous work (28). Data are aver-
ages from 2 independent experiments. (H and I)
Correlation between infection-induced changes to
the SUMO proteome caused by IAV and IBV (H) or
IAV and IAVΔNS1 (I). (J) GO pathway enrichment
analysis of factors that change >2-fold in SUMOylation
during infection with IAV. All pathways with a P
value < 0.001 and >5% identified pathway genes are
shown. Labeling in B–G corresponds to gene names.
See also Datasets S1–S3.
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signature, including increased expression of DDX58 (RIG-I), a
known antiviral sensor for influenza viruses (35), we next per-
formed transcriptomic analysis of IAV-infected wt TRIM28 and
TRIM28-6KR cells. Strikingly, IAV-infected TRIM28-6KR cells
were characterized by a much greater induction of ISGs than
IAV-infected wt TRIM28 cells (Fig. 4D and Dataset S6). This
result was also reflected by looking at significantly enriched
pathways in IAV-infected TRIM28-6KR cells as compared with
IAV-infected wt TRIM28 cells, which included “defense re-
sponse to virus” and “type I IFN signaling” (Fig. 4E and Dataset
S6). Differential gene expression was confirmed for several fac-
tors by specific RT-qPCR (Fig. 4F) and western blot following
IAVΔNS1 infection (SI Appendix, Fig. S5). Overall, these data
suggested that SUMOylation-deficient TRIM28 is unable to
assist in the repression of some canonical innate immune re-
sponse genes, the enhanced expression of which may act to prime
cells for increased antiviral gene expression following infection.
Cells Expressing SUMOylation-Deficient TRIM28 Display Constitutive
Derepression of ERV Elements. Recent depletion studies of
TRIM28 and its associated proteins, such as SETDB1, have
revealed derepression of ERV elements in the absence of these
factors, and an associated triggering of innate immune responses
(6, 9). Mechanistically, this is due to bidirectional transcription
of ERVs and the subsequent formation of immunostimulatory
dsRNAs from annealing of the resulting transcripts (6, 10, 36).
Given the parallels of these previous observations with our own,
together with the noted increase in expression of 3 ERV genes in
our TRIM28-6KR transcriptome dataset, we sought to investigate
whether lack of SUMOylated TRIM28 leads to transcriptional
Fig. 2. Infection-induced loss of SUMOylated
TRIM28 is independent of IFN. (A) Venn diagram
showing an overlap of factors that change in
SUMOylation during infection with IAV, IBV, or
IAVΔNS1. (B) The 71 factors that change in SUMOylation
during all 3 infection conditions were grouped by
their reported nonviral SUMO stress responsiveness
(31) and sorted according to their known impact on
IAV replication (Z-RSA score) (32). See also Dataset
S4. (C–E) A549 cells infected with IAV (MOI = 5 PFU
per cell) (C), IBV (MOI = 5 PFU per cell) (D), or IAV,
IAVΔNS1 (MOI = 2 PFU per cell, 24 h), and IFNα2-
treated (1,000 U/mL, 24 h) (E) were lysed, and sub-
jected to western blot analysis for the indicated
proteins. Data are representative of at least 2 in-
dependent experiments. hpi, hours postinfection. (F)
A549 cells infected with IAV (MOI = 5 PFU per cell,
16 h), IBV (MOI = 5 PFU per cell, 24 h), or IAVΔNS1
(MOI = 5 PFU per cell, 16 h) were lysed, and
SUMOylated proteins were affinity-purified using an
anti-SUMO2/3 antibody. western blot was used to
detect TRIM28 in input and immunoprecipitated (IP)
fractions.
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activation of ERVs that could have immunostimulatory activity.
To this end, we reanalyzed our transcriptome datasets using a
method which allows mapping of repetitive sequences to the
genome and thereby identification of transposable elements
(TEs), such as ERVs, usually excluded from typical RNA-seq
experiments (37). Notably, as our initial transcriptome data
were acquired following the standard procedure of polyA en-
richment, only polyadenylated TEs can be identified in this way.
Nevertheless, using this method, we found a large number of DNA
transposons and retrotransposons significantly up-regulated in
TRIM28-KO cells reconstituted with TRIM28-6KR as compared
with reconstituted with wt TRIM28 (Fig. 5A and Dataset S7).
Among the up-regulated retrotransposons, most appeared to be
long-terminal repeat (LTR) elements that belong to the ERV1,
ERVL, and ERVK subfamilies (Fig. 5 B and C). These data in-
dicate that SUMOylated TRIM28, unlike SUMOylation-deficient
TRIM28, is normally able to repress expression of TEs,
including ERVs.
Derepression of ERV Elements Occurs during IAV Infection. In our
phenotypic studies, we had used the SUMOylation-deficient
TRIM28 construct (TRIM28-6KR) as a surrogate to mimic the
effects of virus-triggered loss of SUMOylated TRIM28 on host
cell biology. We therefore reasoned that IAV infection, as it
leads to loss of SUMOylated TRIM28, should have similar bi-
ological consequences and lead to up-regulation of ERVs. In-
deed, previous studies have found up-regulation of ERV
elements during both IAV and other virus infections (38, 39).
We reanalyzed our IAV-infected transcriptome datasets to allow
mapping of repetitive sequences, and found that IAV infection
(similar to expression of SUMOylation-deficient TRIM28) led to
up-regulation of many cellular TEs (Fig. 5 D and E and Dataset
S7), although it is notable that some TEs from the same sub-
families are also suppressed during infection (Fig. 5F). Overlap
analysis revealed that 59 TEs were up-regulated by both IAV
infection and expression of the SUMOylation-deficient TRIM28
construct (Fig. 5G), and the degree of expression between these
2 independent conditions showed a correlative trend (Fig. 5H).
We also confirmed that SUMO-modified TRIM28 is lost during
IAV infection of primary-like diploid MRC-5 cells concomitant
with ERVV-1 and ERVV-2 induction, suggesting widespread up-
regulation of cellular TEs in primary human cells during in-
fection, similar to that observed in A549 cells (SI Appendix, Fig.
S6). TRIM28 was recently shown to be a repressor of HIV-1 (40,
41), and knockdown of TRIM28 increases expression of HIV-
LTR–driven Firefly luciferase in TZM-bl cells (41). In agreement
with our bioinformatic analyses, IAV infection [similar to
TRIM28 depletion (41)] also induced expression of HIV-LTR–
driven Firefly luciferase in TZM-bl cells (Fig. 5I). These com-
bined analyses suggest that IAV-triggered loss of SUMOylated
TRIM28 causes derepression of ERVs during infection.
Antiviral Activity of SUMOylation-Deficient TRIM28 Relies on IFN
Induction and Signaling. Given that SUMOylation-deficient
TRIM28 failed to suppress expression of ERVs, as well as ex-
pression of an innate immune defense gene signature, we sought to
determine if, and how, these activities were responsible for medi-
ating the antiviral function of SUMOylation-deficient TRIM28
against IAV. ERV transcription is usually thought to stimulate
MAVS-based innate immune responses as dsRNA (via bidirectional
Fig. 3. SUMOylated TRIM28 is required to support
efficient virus replication. (A) western blot analysis
of TRIM28 knockout A549 cells (TR28 KO#1), or
nontargeted control A549 cells (Ctrl), reconstituted
with TRIM28 or empty vector (ev) by lentiviral
transduction. Data are representative of at least 2
independent experiments. (B) Cell number per well
of the cells described in A, 24 h after seeding equal
numbers of cells. Mean values from 3 independent
experiments are plotted, with error bars represent-
ing SDs and individual data points shown. (C and D)
Cells described in A were infected with IAV at MOI =
0.001 PFU per cell, and supernatants were collected
at the indicated times prior to titration (growth
curve plotted in C; 72 hpi only plotted in D). Mean
values from 3 independent experiments are plotted,
with error bars representing SDs. For D, individual
data points are shown in addition. (E) Schematic of
TRIM28 showing the RING domain, 2 B-box zinc
finger domains (B1 and B2), coil-coiled domain (CC),
HP1 binding site (HP1), PHD and bromo (BR) do-
mains, and all known SUMOylation sites (K554,
K575, K676, K750, K779, and K804). In the TRIM28-
6KR mutant, the 6 SUMOylation sites are all changed
to arginine. (F) Cotransfection of Flag-tagged con-
structs expressing wt TRIM28 or TRIM28-6KR to-
gether with His-SUMO1 or His-SUMO2 into 293T cells
followed by cell lysis and western blot analysis using
a Flag-specific antibody or actin antibody. Data are
representative of at least 2 independent experi-
ments. (G) western blot analysis of TRIM28 knockout
A549 cells (TR28 KO#1), or nontargeted control
A549 cells (Ctrl), reconstituted with wt TRIM28,
TRIM28-6KR, or empty vector by lentiviral trans-
duction. Data are representative of at least 2 in-
dependent experiments. (H) Cells described in G
were infected with IAV at MOI = 0.001 PFU per cell,
and supernatants were collected at 72 hpi prior to
titration. Mean values from 3 independent experiments are plotted, error bars represent SDs, and individual data points are shown. For B, significance was
determined by unpaired t test, and for C, D, and H by 1-way ANOVA (**P < 0.01, ***P < 0.001; ns, nonsignificant).
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transcription and annealing of cRNA transcripts), but cGAS-
STING agonistic cDNA can also be generated by reverse-
transcriptase activity (42) (Fig. 6A). To dissect these 2 possibil-
ities in our system, we applied CRISPR/Cas9 to our existing
TRIM28-KO (and Ctrl) cells to generate MAVS or STING KOs
in the presence or absence of TRIM28. Strikingly, knockout of
MAVS, but not STING, fully restored the replication of IAV in
TRIM28-KO cells, suggesting that TRIM28-repressed ERVs
potentiate a MAVS-dependent dsRNA-mediated response (Fig.
6 B and C). A similar strategy revealed that this effect was also
dependent upon RIG-I, but not MDA5 (Fig. 6 D and E). To
expand these observations to the functions of SUMOylation-
deficient TRIM28, we made use of commercially available
small-molecule inhibitors of the dsRNA-mediated IFN induction
cascade (BX-795, an inhibitor of TBK1) and the IFN signaling
cascade (ruxolitinib, an inhibitor of JAK1) (Fig. 6A). Notably,
treatment with either inhibitor restored the ability of IAV to
replicate efficiently in TRIM28-KO cells reconstituted with
TRIM28-6KR, so that replication was similar to TRIM28-KO
cells reconstituted with wt TRIM28 (Fig. 6 F and G). These
data indicate that SUMOylation-deficient TRIM28, which can-
not restrain aberrant immunostimulatory ERV expression, likely
stimulates and primes IFN-mediated innate immune defenses to
restrict IAV replication via a RIG-I–, MAVS-, TBK1-, and
JAK1-dependent pathway.
Discussion
Herein, we aimed to provide a comprehensive proteomic survey
of host SUMOylation responses to diverse influenza virus in-
fection states, including under conditions where virus-mediated
innate immune suppression has been abrogated. This resource,
encompassing dynamic SUMO modification changes to almost
600 host proteins, will permit future investigations into the
contribution of specific SUMOylation events to both influenza
virus biology and innate immunity.
The major experimental focus of this study was to determine the
consequences of infection-triggered loss of SUMOylated TRIM28,
a cellular reaction to all 3 influenza virus infection states that we
found to be independent of canonical innate immune stimulation
and DNA damage-like stimuli involving the ATM kinase. Thus,
the infection-triggered loss of SUMOylated TRIM28 observed
here does not appear to be related to well-characterized
phosphorylation-dependent switches in TRIM28 activities, which
have previously been linked to regulating DNA virus latency,
DNA damage repair, the cell cycle, and inflammatory responses
to infection (21, 43, 44). Indeed, TRIM28 SUMOylation, but not
phosphorylation, has been specifically implicated in repression of
transcription from integrated retroviral genomes (45), indicat-
ing phenotypically distinct activities for different TRIM28 post-
translational modifications. By combining genetics, transcriptomics,
and classical virology, we report that infection-triggered loss of
Fig. 4. Cells expressing SUMOylation-deficient
TRIM28 exhibit an increased innate immune de-
fense gene signature and are primed for triggering
enhanced IFN-stimulated responses during infection.
(A and D) Transcriptome analysis comparing TRIM28-
KO A549 cells reconstituted with wt TRIM28 or
TRIM28-6KR, which were mock infected (A) or in-
fected with IAV (MOI = 10 PFU per cell, 6 h) (D). Data
are derived from 3 independent replicates. Genes
with a P < 0.001 and fold change 6KR/wt >2.5 or
<−2.5 are depicted in blue (zinc finger proteins),
orange (IFN-stimulated genes), purple (ERVs), or black
(others). ISGs were identified using an online data-
base [http://isg.data.cvr.ac.uk (62)]. (B and E) GO
pathway enrichment analysis of genes significantly
up-regulated (P < 0.001 and fold change > 2.5) in
cells expressing TRIM28-6KR under mock (B) or in-
fected (E) conditions, showing the 6 most signifi-
cantly enriched pathways. (C and F) Differential
expression of selected genes was validated by RT-
qPCR analysis under mock (C) or IAV infection (F)
conditions as described in A and D. Bars represent
mean values and SDs of 3 independent experiments
(each dot represents 1 replicate). Significance was
determined by unpaired t test (*P < 0.05, **P < 0.01,
***P < 0.001; ns, nonsignificant). See also Datasets
S5 and S6.
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SUMOylated TRIM28 constitutes a previously unrecognized
mechanism for the cell to mount innate immune defenses. Our
data suggest a model (Fig. 7) whereby loss of SUMOylated
TRIM28 disrupts its ability to form a functional repressor complex,
causing the predominant transcriptional up-regulation of LTR-
containing ERV elements. ERVs have been reported to exhibit
bidirectional transcription, with the subsequent transcripts anneal-
ing to form immunostimulatory dsRNAs (6, 10, 36). In line with
this, we provide evidence that engineered deficiency in SUMOy-
lated TRIM28 leads to an enhanced IFN-mediated antiviral
response acting via canonical components of dsRNA-sensing
pathways, such as RIG-I, MAVS, TBK1, and JAK/STAT. These
observations support a model whereby this infection-triggered
SUMO switch leads to aberrant up-regulation of self ERV RNAs
that are sensed as non-self by PRRs (Fig. 7). Notably, while RIG-I
(but not MDA5) is the critical sensor of influenza virus genomes
(35), MDA5 can play a clear antiviral role against influenza viruses
(46), and other studies have implicated ERV-derived dsRNA as
both an MDA5 and RIG-I agonist (5–7). We therefore do not rule
out that both RIG-I and MDA5 may act to sense IAV infection-
triggered increases in self ERV-derived dsRNA to promote antiviral
activity. A further tempting speculation to make is that infection–
up-regulated ERV dsRNA is a target for the major influenza virus
IFN-antagonist protein NS1, whose viral and host dsRNA targets
have remained enigmatic. Indeed, it is clear from the proteomic
work presented here that wild-type IAVs generally do not induce an
innate immune response, despite triggering up-regulation of
immunostimulatory ERV RNAs. Thus, wild-type IAVs must be
able to mitigate the antiviral effects of ERV up-regulation, and we
hypothesize that the sequence-independent dsRNA-binding activity
of IAV NS1, which can oligomerize around both long and short
dsRNAs (47), antagonizes IFN induction in response to ERVRNA
(Fig. 7). Alternatively, NS1 (and other viral factors) might directly
inhibit ERV-mediated activation of RIG-I/MAVS signaling (48).
The viral component that triggers the cellular SUMO switch
stress response in TRIM28 has yet to be precisely defined, but viral
polymerase activity could play a role given that this nuclear event
can cause widespread SUMO remodeling (28). Future work to
determine the specific viral trigger for this reaction, as well as the
cellular factors driving the loss of SUMOylated TRIM28, will have
important implications for our understanding of the molecular
players that fully contribute to host protection against viruses.
In sum, the infection-triggered SUMO switch mechanism de-
scribed here provides a new example of how the traditional clear-
cut paradigm of cells detecting self versus non-self is being eroded,
and highlights the important emerging roles that stress-induced self
RNAs play in innate immune defenses (11–13). Our data contrib-
ute to the increasing recognition that ERV sequences have been co-
opted as critical orchestrators of host antiviral immunity (49, 50).
Materials and Methods
Cells and Viruses. A549, MDCK, 293T, and TZM-bl cells (51) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Life Technologies) supple-
mented with 10% (vol/vol) FCS, 100 units/mL penicillin, and 100 μg/mL
streptomycin (Gibco Life Technologies). MRC-5 cells were cultured in minimum
essential medium Eagle supplemented with 10% (vol/vol) FCS, 100 units/mL
penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine, and 1% (vol/vol) nones-
sential amino acids (Life Technologies). A549 cells stably expressing TAP-tagged
Fig. 5. Up-regulation of transposable elements in
cells expressing SUMOylation-deficient TRIM28 and
during IAV infection. (A and D) Transcriptome
datasets from Fig. 4 were reanalyzed for expression
of repetitive elements comparing TRIM28-KO
A549 cells reconstituted with wt TRIM28 versus
TRIM28-6KR (A), or mock versus IAV-infected
TRIM28-wt A549 cells (D). Elements with a P
value < 0.05 and fold change >1.5 or <−1.5 are
depicted in blue (DNA transposons), orange (retro-
transposons), or black (others). (B, C, E, and F) Sub-
classes of retrotransposons that were significantly
up- or down-regulated in TRIM28-6KR–expressing
cells (B and C) or during IAV infection (E and F): LINE,
long interspersed nuclear element; LTR, long-terminal
repeat retrotransposon; SINE, short interspersed
nuclear element. (G) Overlap analysis of TEs that are
significantly up-regulated in TRIM28-6KR–expressing
cells (TR28-6KR) and during IAV infection. (H) Fold-
change correlation between the 59 TEs that are
up-regulated in TRIM28-6KR cells and during IAV
infection. Elements are depicted in blue (DNA
transposons), orange (retrotransposons), or black
(others). (I) TZM-bl cells that express Firefly luciferase
under control of an LTR were infected with IAV
(MOI = 50 PFU per cell) or mock infected. Firefly lu-
ciferase was measured at 16 hpi. Bars represent
mean values and SDs of 3 independent experiments
(each dot represents 1 replicate). Significance was
determined by unpaired t test (**P < 0.01). See also
Dataset S7.
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SUMO1 or SUMO2 were described previously (28). To generate TRIM28-KO and
control cells, A549 cells were transiently transfected with pSpCas9.sgTRIM28-2A-
GFP or pSpCas9.sgFfluc-2A-GFP plasmids (see below) using Lipofectamine 3000
(ThermoFisher) at a 1:1 DNA:transfection reagent ratio. GFP-positive cells were
obtained by FACS and seeded at 100 cells per 10-cm dish. Clonal cell colonies
were expanded and screened for TRIM28 expression by western blot. To rein-
troduce expression of wt TRIM28 or mutants, cells were transduced with lenti-
viral particles produced by cotransfection of 293T cells with the respective pLVX-
IRES-Puro (Clontech)–derived construct, pMD2.G, and pCMVdR8.91. Forty-eight
hours after transduction, cells were subjected to puromycin selection (1 μg/mL).
Influenza virus stocks A/WSN/33 (IAV), A/WSN/33ΔNS1 (IAVΔNS1), and B/Yamagata/
88 (IBV) were grown in MDCKs or eggs (as appropriate).
Plasmids. To generate constructs for the CRISPR/Cas9 systems, oligos encoding
single-guide RNAs (sgRNAs) (Dataset S8) were annealed, phosphorylated, and
inserted into lentiCRISPRv2 plasmid [gift from Feng Zhang, Massachusetts
Institute of Technology, Boston MA; Addgene plasmid 52961 (52)] or
pSpCas9(BB)-2A-GFP [gift from Feng Zhang; Addgene plasmid 48138 (53)].
Fig. 6. Antiviral activity of SUMOylation-deficient TRIM28 relies on dsRNA-mediated IFN induction and signaling pathways. (A) Schematic showing the
canonical IFN signaling cascade triggered by ERV transcripts and leading to ISG expression. Stages of action of specific small-molecule inhibitors are shown. (B)
TRIM28-KO (and Ctrl) A549 cells were transduced with lentiviruses expressing Cas9 and 3 different sgRNAs targeting MAVS, STING, or GFP (negative control).
Selected cell pools were subsequently infected with IAV (MOI = 0.001 PFU per cell) and supernatants were collected at 72 hpi prior to titration. (C) Cells
generated for B were processed for western blot to assess knockout efficiency. Data are representative of at least 2 independent experiments. (D) TRIM28-KO
(and Ctrl) A549 cells were transduced with lentiviruses expressing Cas9 and 3 different sgRNAs targeting RIG-I, MDA5, or GFP (negative control). Selected cell
pools were subsequently infected with IAV (MOI = 0.001 PFU per cell) and supernatants were collected at 72 hpi prior to titration. (E) Cells generated for D
were treated with IFNα2 (1,000 U/mL, 16 h) and processed for western blot to assess knockout efficiency. Data are representative of at least 2 independent
experiments. (F and G) TRIM28-KO A549 cells reconstituted with wt TRIM28 or TRIM28-6KR were infected with IAV (MOI = 0.001 PFU per cell) in the presence
or absence of the TBK1 inhibitor BX-795 (0.5 μM; F) or the JAK1 inhibitor ruxolitinib (4 μM; G) for 72 h, prior to titration of supernatants. For B, D, F, and G,
mean values from 3 independent experiments are plotted, error bars represent SDs, and individual data points are shown. Significance was determined by 1-
way ANOVA (**P < 0.01, ***P < 0.001, ****P < 0.0001; ns, nonsignificant).
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To generate TRIM28 expression plasmids, TRIM28 was PCR-amplified from
pEGFP-TRIM28 [gift from Fanxiu Zhu, Florida State University, Tallahassee,
FL; Addgene plasmid 45568 (54)] and inserted between the EcoRI and XbaI
sites of p3xFLAG-CMV-7.1 (Sigma-Aldrich). TRIM28-6KR, TRIM28 N-3KR,
TRIM28 3KR-C, and TRIM28 delBR mutants were generated by subsequent
site-directed mutagenesis (QuikChange II XL; Agilent Technologies). The
TRIM28 delRING mutant was generated by PCR, where nucleotides 1 to
192 and nucleotides 364 to 2,508 were amplified in the first PCR, followed by
a second PCR to fuse the 2 fragments together. All primer sequences are
listed in Dataset S8. As necessary, inserts were subcloned into pLVX-IRES-
Puro. The identity of inserts in each construct was confirmed by Sanger se-
quencing. pLVX-6His-SUMO1 and pCAGGS-6His-SUMO2 plasmids were de-
scribed previously (55).
Transient Transfection. Generally, 1.5 × 105 293T cells were seeded per well of
a 24-well plate and transfected the next day with 300 to 500 ng of each of
the indicated constructs using FuGENE HD transfection reagent (Promega) at
a 1:3 DNA:transfection reagent ratio.
Lenti-CRISPR Knockout System. 293T cells were transfected with a pool of 3
lentiCRISPRv2 plasmids targeting each gene of interest (Dataset S8), together
with the appropriate packaging plasmids. At 48 h posttransfection, the su-
pernatant was harvested and used to transduce A549 cells prior to puro-
mycin selection (1 μg/mL).
Virus Infection. Generally, 2 × 105 cells were seeded per well of a 12-well
plate and infected the next day at the indicated multiplicity of infection
(MOI). Cells from separate wells were trypsinized and counted to determine
cell number. Virus inoculum was prepared in PBS supplemented with 0.3%
BSA, 1 mM Ca2+/Mg2+, 100 units/mL penicillin, and 100 μg/mL streptomycin.
Cells were incubated with the inoculum for 1 h, washed 3 times with PBS,
and then overlaid with DMEM supplemented with 0.1% FBS, 0.3% BSA,
20 mM Hepes, 100 units/mL penicillin, and 100 μg/mL streptomycin. Where
indicated, IFNα2a (Roferon-A; Roche), etoposide (Sigma-Aldrich; E1383),
KU55933 (Sigma-Aldrich; SML1109), MG132 (Sigma-Aldrich; M7449), lacta-
cystin (Enzo Life Sciences; BML-PI104-0200), ruxolitinib (Santa Cruz; sc-
364729), or BX-795 (Sigma-Aldrich; SML0694) was added to the medium at
the indicated concentration. Virus titers in the supernatants at the indicated
time points were determined by standard plaque assay on MDCK cells. All
infections with IBV were performed at 33 °C, while 37 °C was used for all
other conditions.
SILAC, TAP, Mass Spectrometry, and Bioinformatic Analysis.Mass spectrometry
analyses of SUMOylated proteins following the indicated infections were
performed as described previously (28). Infection times differed for each
virus to allow maximal replication before appearance of any cytopathic ef-
fects. Data processing was carried out according to previously described
protocols (28), with all cutoffs and processing steps detailed on the “Info”
tabs of each appropriate table (Datasets S1–S3). The raw mass spectrometry
proteomics data have been deposited in the ProteomeXchange Consortium
via the PRIDE (56) partner repository with the dataset identifier PXD014136.
Pathway enrichment analyses were performed using DAVID (30).
Western Blot Analysis. Cell lysates were generated and processed according to
previously described protocols (28). Proteins were transferred to nitrocellu-
lose membranes (Amersham) and detected using the following primary
antibodies: β-actin (Santa Cruz; sc-47778), TRIM28 (Bethyl; A300-27A),
phospho-TRIM28 Ser824 (abcam; ab70369), IAV-NS1 (pAb 155; gift from
Peter Palese, Icahn School of Medicine at Mount Sinai, New York, NY), IBV-
NP (abcam; ab20711), RIG-I (gift from Adolfo García-Sastre, Icahn School of
Medicine at Mount Sinai, New York, NY), PKR (abcam; ab32052), MDA5 (Cell
Signaling; 5321), MAVS (Cell Signaling; 2992), STING (Cell Signaling; 13647),
FLAG M2 (Sigma; F1804), and ubiquitin FK2 (Millipore; 04-263).
SUMO Immunoprecipitation Assay. SUMOylated proteins were enriched by
immunoprecipitation as described previously (28).
Transcriptome Analysis by Illumina RNA Sequencing.
Library preparation. Total RNA from 3 independent replicates was isolated and
quality was determined using aQubit 1.0 fluorometer (Life Technologies) and
Bioanalyzer 2100 (Agilent). TruSeq RNA Sample Prep Kit v2 (Illumina) was
used in subsequent steps. Briefly, total RNA (100 to 1,000 ng) was polyA-
enriched before reverse transcription into double-stranded cDNA. cDNA
samples were fragmented, end-repaired, and polyadenylated before ligation
of TruSeq adapters containing the multiplexing index. Fragments containing
TruSeq adapters on both endswere selectively enrichedwith PCR. Quality and
quantity of the enriched libraries were validated using a Qubit 1.0 fluo-
rometer and LabChip GX (Caliper Life Sciences). The product was a smear with
an average fragment size of ∼260 bp. Libraries were normalized to 10 nM in
10 mM Tris·Cl (pH 8.5) with 0.1% Tween 20. Adapter sequences for TruSeq
RNA and DNA Sample Prep Kits are listed in Dataset S8.
Cluster generation and sequencing. The TruSeq PE Cluster Kit HS4000 or TruSeq
SR Cluster Kit HS4000 (Illumina) was used for cluster generation using 10 pM
pooled normalized libraries on the cBOT. Sequencing was performed on the
Illumina HiSeq 4000 (single-end, 125 bp) using the TruSeq SBS Kit HS4000
(Illumina).
Data analysis. Reads were quality-checked with FastQC. Sequencing adapters
were removed with Trimmomatic (57) and reads were subjected to hard
trimming by 5 bases at the 3′ end. Successively, reads >20 bases long, and
with an overall average phred quality score >10, were aligned to the ref-
erence genome and transcriptome of Homo sapiens (FASTA and GTF files,
respectively, downloaded from GRCh38) with STAR v2.5.1 (58), with default
settings for single-end reads. Distribution of the reads was quantified using
the R package GenomicRanges (59), and differentially expressed genes were
identified using the R package edgeR (60) (both from Bioconductor version
3.0). The RNA-seq data have been deposited in NCBI’s Gene Expression Om-
nibus (61) and are accessible through GEO series accession no. GSE133329.
Repetitive element analysis. Analysis of repetitive elements was performed as
described previously (37).
RT-qPCR Analysis. Cellular RNA was extracted using the ReliaPrep RNA Cell Kit
(Promega) and cDNA was synthesized from 1 μg RNA using SuperScript III
reverse transcriptase (ThermoFisher) and random primers (Promega). cDNA
was diluted 1:5 with water and RT-qPCR was performed using Fast Eva-
Green qPCR Master Mix (Biotium) and 0.2 μM forward and reverse primers
(listed in Dataset S8) in the 7300 Real-Time PCR System (Applied Bio-
systems) with the following thermal cycling protocol: 10 min at 95 °C,
40 cycles of 15 s at 95 °C and 1 min at 60 °C, followed by a dissociation
stage from 60 to 95 °C to confirm primer specificity. The relative gene
expression was calculated with the ΔΔCt method, using either GAPDH or 18S
rRNA for normalization.
Luciferase Assay. TZM-bl cells (4 × 104 per well) were seeded in a 96-well plate
and infected with IAV (or mock) as indicated. At 16 h postinfection, Firefly
luciferase activity was analyzed using the ONE-Glo Luciferase Assay System
(Promega) according to the manufacturer’s instructions.
Statistical Analysis. Statistical analyses were performed using GraphPad Prism
7 software. Virus titer data were log-transformed and analyzed by unpaired
2-tailed t test or 1-way ANOVA for comparison of multiple conditions. For
Fig. 7. Model of the infection-triggered TRIM28 SUMO switch leading to
increased antiviral responses. Upon loss of SUMOylated TRIM28, transcrip-
tional repression of ERVs is released, leading to formation of dsRNA that is
sensed by cellular PRRs, such as RIG-I, which induce activation of the ca-
nonical antiviral IFN system. Viral dsRNA-binding proteins, such as NS1, may
act as antagonists of this pathway.
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RT-qPCR data, ΔCt values were analyzed by unpaired 2-tailed t test. The P
values for significance are stated in the figure legends.
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